Successful recovery from a subclavicular ulcer caused by lenvatinib for thyroid cancer: a case report

BACKGROUND: There are currently no effective therapeutic methods for locally recurrent, metastatic, or progressive radioactive iodine (RAI)-refractory differentiated thyroid cancer. However, multitargeted tyrosine kinase inhibitors (TKIs) such as lenvatinib or sorafenib have been approved for patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitamura, Morimasa, Hayashi, Tomomasa, Suzuki, Chiaki, Hirano, Shigeru, Tateya, Ichiro, Kishimoto, Yo, Omori, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237504/
https://www.ncbi.nlm.nih.gov/pubmed/28088233
http://dx.doi.org/10.1186/s12957-017-1096-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237504/
https://www.ncbi.nlm.nih.gov/pubmed/28088233
http://dx.doi.org/10.1186/s12957-017-1096-5

Ejemplares similares